ZIC2 Is Essential for Maintenance of Latency and Is a Target of an Immediate Early Protein during Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.

Lyu, Yuanzhi; Nakano, Kazushi; Davis, Ryan R; Tepper, Clifford G; Campbell, Mel; Izumiya, Yoshihiro

Lyu, Yuanzhi; Nakano, Kazushi; Davis, Ryan R; Tepper, Clifford G; Campbell, Mel; Izumiya, Yoshihiro.

Afiliação

Lyu Y; Department of Dermatology, School of Medicine, University of California, Davis, Sacramento, California, USA.
Nakano K; Department of Dermatology, School of Medicine, University of California, Davis, Sacramento, California, USA.
Davis RR; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
Tepper CG; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
Campbell M; University of California, Davis, Comprehensive Cancer Center, Sacramento, California, USA.
Izumiya Y; Department of Dermatology, School of Medicine, University of California, Davis, Sacramento, California, USA.

J Virol ; 91(21)2017 Nov 01.

Article em En | MEDLINE | ID: mdl-28835494

Palavras-chave

Kaposi's sarcoma-associated herpesvirus; PRC2; ZIC2; epigenetic; reactivation; transcriptional regulation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Virol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google